Additional Advances in Neuroendocrine Tumor Research and Clinical Trials With Aman Chauhan, MD

The treatment landscape for neuroendocrine tumors (NETs) is undergoing a period of accelerated progress, with new epidemiologic insights, targeted therapies, and novel immunotherapeutic approaches reshaping clinical practice. Aman Chauhan, MD, Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF), recently chaired i3 Health’s CME activity, Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care. With several important developments emerging in recent months, Dr. Chauhan sat down again to share key updates that are influencing how clinicians approach the treatment of NETs. Click below to view the full activity and claim your free credit! Online Activity: https://i3health.com/course-information/optimizing-neuroendocrine-tumor-outcomes-closing-the-gaps-in-diagnosis-and-care Downloadable Infographic: https://www.slideshare.net/slideshow/infographic-optimizing-neuroendocrine-tumor-outcomes/283784320?utm_source=clipboard_share_button&utm_campaign=slideshare_make_sharing_viral_v2&utm_variation=control&utm_medium=share